Total submissions: 10
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001837971 | SCV000659269 | benign | Hypercholesterolemia, autosomal dominant, type B; Familial hypobetalipoproteinemia 1 | 2025-02-04 | criteria provided, single submitter | clinical testing | |
Robarts Research Institute, |
RCV000660667 | SCV000782816 | likely benign | Hypercholesterolemia, familial, 1 | 2018-01-02 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000771134 | SCV000902918 | likely benign | Familial hypercholesterolemia | 2017-06-26 | criteria provided, single submitter | clinical testing | |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV001281699 | SCV001133394 | benign | not specified | 2019-08-26 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000560486 | SCV001152098 | likely benign | not provided | 2024-05-01 | criteria provided, single submitter | clinical testing | APOB: BP4, BP7 |
Illumina Laboratory Services, |
RCV001136657 | SCV001296513 | uncertain significance | Familial hypobetalipoproteinemia 1 | 2017-08-01 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. However, the evidence from the literature, in combination with allele frequency data from public databases where available, was not sufficient to rule this variant in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. |
Illumina Laboratory Services, |
RCV001136658 | SCV001296514 | benign | Hypercholesterolemia, autosomal dominant, type B | 2017-08-01 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to rule this variant out of causing disease. Therefore, this variant is classified as benign. |
Gene |
RCV000560486 | SCV001823976 | likely benign | not provided | 2021-09-27 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002384271 | SCV002702218 | likely benign | Cardiovascular phenotype | 2018-02-05 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
GENin |
RCV000771134 | SCV005441591 | likely benign | Familial hypercholesterolemia | 2023-09-11 | criteria provided, single submitter | clinical testing | This is a synonymous (silent) variant that is not predicted by SpliceAI to impact splicing. In addition, it occurs at a nucleotide that is not conserved. Therefore this variant has been classified as Likely Benign (BP4, BP7). |